43 Determinants of (non)attendance at the Dutch CSPs 53. Wools A, Dapper EA, Leeuw JRJD. Colorectal cancer screening participation: A systematic review. European Journal of Public Health 2016; 26: 158-168. 54. Fylan F. Screening for cervical cancer: a review of women’s attitudes, knowledge, and behaviour. Br J Gen Pract 1998; 48: 1509-1514. 55. Vernon SW. Participation in colorectal cancer screening: a review. Journal of the National Cancer Institute 1997; 89: 1406-1422. 56. Spadea, T., Bellini, S., Kunst, A., Stirbu, I., & Costa, G. (2010). The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: a review. Preventive medicine, 50(4), 159-164. 57. Reath, J., & Carey, M. (2008). Breast and cervical cancer in Indigenous women: overcoming barriers to early detection. Australian family physician, 37(3), 178. 58. de Klerk CM, Gupta S, Dekker E, Essink-Bot ML. Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide. Gut 2017; 67.4: 679-687. 59. Ketelaars PJW, Bosgraaf RP, Siebers AG et al. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study. Preventive Medicine 2017; 101: 96-101. 60. Gezondheidsraad. Screening op baarmoederhalskanker. 2011; publicatienr. 2011/07. ISBN 978-90-5549-841-3. 2
RkJQdWJsaXNoZXIy MTk4NDMw